(19)
(11) EP 4 815 965 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898789.3

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 31/7125(2006.01)
A61K 31/712(2006.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
C12N 15/113(2010.01)
A61K 31/7115(2006.01)
A61K 31/713(2006.01)
A61K 47/54(2017.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2818; C07K 2317/76; A61K 39/395; A61K 31/713; C12N 15/113; C12N 2310/14; C12N 2310/315; C12N 2310/321; C12N 2310/3341; C12N 2310/3515; C12N 2310/312; C12N 2310/335; C12N 2310/322
 
C-Sets:
  1. A61K 39/395, A61K 2300/00;
  2. A61K 31/713, A61K 2300/00;
  3. C12N 2310/321, C12N 2310/3521;
  4. C12N 2310/322, C12N 2310/3533;

(86) International application number:
PCT/US2024/057805
(87) International publication number:
WO 2025/117786 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603276 P

(71) Applicant: Phio Pharmaceuticals Corp.
King of Prussia, PA 19406 (US)

(72) Inventors:
  • MAXWELL, Melissa
    Clinton, MA 01510 (US)
  • CARDIA, James
    Franklin, MA 02038 (US)
  • FRICKER, Simon
    North Grafton, MA 01536 (US)
  • CUIFFO, Benjamin
    Natick, MA 01760 (US)

(74) Representative: Potter Clarkson 
Chapel Quarter Mount Street
Nottingham NG1 6HQ
Nottingham NG1 6HQ (GB)

   


(54) ENHANCED COMBINATION IMMUNE CHECKPOINT INHIBITION THERAPY UTILIZING RNAI